tiprankstipranks
Trending News
More News >
HCA Healthcare (HCA)
NYSE:HCA
US Market

HCA Healthcare (HCA) Ratios

Compare
1,778 Followers

HCA Healthcare Ratios

HCA's free cash flow for Q4 2025 was $0.42. For the 2025 fiscal year, HCA's free cash flow was decreased by $ and operating cash flow was $0.17. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
0.83 0.83 1.08 1.18 1.38
Quick Ratio
0.73 0.73 0.97 1.02 1.17
Cash Ratio
0.06 0.06 0.13 0.07 0.09
Solvency Ratio
0.16 0.16 0.15 0.15 0.16
Operating Cash Flow Ratio
0.77 0.77 0.69 0.75 0.86
Short-Term Operating Cash Flow Coverage
1.87 1.87 2.24 3.89 23.03
Net Current Asset Value
$ -49.93B$ -49.93B$ -42.54B$ -40.22B$ -38.87B
Leverage Ratios
Debt-to-Assets Ratio
0.83 0.83 0.76 0.74 0.77
Debt-to-Equity Ratio
-8.33 -8.33 -18.10 -23.60 -14.53
Debt-to-Capital Ratio
1.14 1.14 1.06 1.04 1.07
Long-Term Debt-to-Capital Ratio
1.17 1.17 1.07 1.05 1.08
Financial Leverage Ratio
-10.07 -10.07 -23.81 -31.69 -18.95
Debt Service Coverage Ratio
1.51 1.51 1.78 2.55 5.47
Interest Coverage Ratio
5.32 5.32 5.12 4.97 5.21
Debt to Market Cap
0.41 0.45 0.55 0.54 0.54
Interest Debt Per Share
227.32 227.32 182.90 160.78 144.44
Net Debt to EBITDA
3.15 3.15 3.12 3.22 2.96
Profitability Margins
Gross Profit Margin
41.50%41.50%40.62%39.37%38.48%
EBIT Margin
15.98%15.98%14.99%14.84%17.14%
EBITDA Margin
20.64%20.64%19.68%19.58%22.06%
Operating Profit Margin
15.83%15.83%14.94%14.82%15.03%
Pretax Profit Margin
13.01%13.01%12.07%11.86%14.24%
Net Profit Margin
8.97%8.97%8.16%8.07%9.37%
Continuous Operations Profit Margin
10.29%10.29%9.43%9.38%11.35%
Net Income Per EBT
69.00%69.00%67.58%68.02%65.77%
EBT Per EBIT
82.17%82.17%80.81%80.05%94.78%
Return on Assets (ROA)
11.17%11.17%9.68%9.33%10.76%
Return on Equity (ROE)
-140.78%-112.56%-230.49%-295.49%-203.94%
Return on Capital Employed (ROCE)
26.97%26.97%23.79%22.10%21.28%
Return on Invested Capital (ROIC)
18.53%18.53%16.68%16.42%16.66%
Return on Tangible Assets
13.45%13.45%11.66%11.33%13.19%
Earnings Yield
5.52%6.30%7.42%7.11%8.10%
Efficiency Ratios
Receivables Turnover
6.96 6.96 6.57 6.52 6.77
Payables Turnover
9.49 9.49 9.80 9.31 8.74
Inventory Turnover
26.77 26.77 24.12 19.49 17.92
Fixed Asset Turnover
2.43 2.43 2.24 2.17 2.18
Asset Turnover
1.25 1.25 1.19 1.16 1.15
Working Capital Turnover Ratio
-27.99 -97.30 40.24 21.61 15.64
Cash Conversion Cycle
27.65 27.65 33.48 35.45 32.49
Days of Sales Outstanding
52.47 52.47 55.58 55.95 53.88
Days of Inventory Outstanding
13.63 13.63 15.13 18.73 20.37
Days of Payables Outstanding
38.45 38.45 37.23 39.23 41.75
Operating Cycle
66.10 66.10 70.71 74.67 74.25
Cash Flow Ratios
Operating Cash Flow Per Share
54.77 54.77 40.66 34.62 29.35
Free Cash Flow Per Share
33.34 33.34 21.81 17.21 14.21
CapEx Per Share
21.43 21.43 18.85 17.42 15.14
Free Cash Flow to Operating Cash Flow
0.61 0.61 0.54 0.50 0.48
Dividend Paid and CapEx Coverage Ratio
2.25 2.25 1.89 1.74 1.69
Capital Expenditure Coverage Ratio
2.56 2.56 2.16 1.99 1.94
Operating Cash Flow Coverage Ratio
0.25 0.25 0.23 0.23 0.21
Operating Cash Flow to Sales Ratio
0.17 0.17 0.15 0.15 0.14
Free Cash Flow Yield
6.45%7.14%7.26%6.36%5.92%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
18.13 15.88 13.48 14.07 12.35
Price-to-Sales (P/S) Ratio
1.58 1.42 1.10 1.13 1.16
Price-to-Book (P/B) Ratio
-20.40 -17.87 -31.06 -41.56 -25.18
Price-to-Free Cash Flow (P/FCF) Ratio
15.49 14.00 13.76 15.73 16.88
Price-to-Operating Cash Flow Ratio
9.73 8.52 7.38 7.82 8.18
Price-to-Earnings Growth (PEG) Ratio
1.94 0.56 0.86 -13.67 -1.28
Price-to-Fair Value
-20.40 -17.87 -31.06 -41.56 -25.18
Enterprise Value Multiple
10.79 10.05 8.70 9.01 8.20
Enterprise Value
168.34B 156.87B 120.92B 114.66B 108.96B
EV to EBITDA
10.79 10.05 8.70 9.01 8.20
EV to Sales
2.23 2.07 1.71 1.76 1.81
EV to Free Cash Flow
21.89 20.39 21.44 24.46 26.40
EV to Operating Cash Flow
13.32 12.41 11.50 12.16 12.79
Tangible Book Value Per Share
-56.63 -56.63 -36.88 -32.62 -33.50
Shareholders’ Equity Per Share
-26.12 -26.12 -9.66 -6.51 -9.53
Tax and Other Ratios
Effective Tax Rate
0.21 0.21 0.22 0.21 0.20
Revenue Per Share
327.68 327.68 273.02 238.50 207.45
Net Income Per Share
29.40 29.40 22.27 19.24 19.44
Tax Burden
0.69 0.69 0.68 0.68 0.66
Interest Burden
0.81 0.81 0.81 0.80 0.83
Research & Development to Revenue
0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
0.21 0.11 0.44 0.45 0.46
Stock-Based Compensation to Revenue
<0.01 0.00 <0.01 <0.01 <0.01
Income Quality
1.75 1.86 1.58 1.80 1.25
Currency in USD